Literature DB >> 17880559

Correlation of a high D-dimer level with poor outcome in traumatic intracranial hemorrhage.

J-R Kuo1, K-C Lin, C-L Lu, H-J Lin, C-C Wang, C H Chang.   

Abstract

The correlations between D-dimer and Glasgow Coma Scale (GCS), pupillary light reflex, distance of midline shift on brain computed tomography (CT), and Glasgow Outcome Score (GOS) in patients with trauma/non-trauma intracranial hemorrhage (ICH) are not consistent in studies. Ninety-eight traumatic and 59 non-traumatic ICH patients were studied. Pre-existing venous thrombosis, recent surgery, drug use (aspirin or coumadin), or malignancy, were excluded. D-dimer level was estimated within hours after acute insult, and statistical analyses were used for comparisons between groups. Traumatic ICH patients had higher D-dimer levels than controls (2984 vs. 256 microg/l; P = 0.001). The GCS, midline shift on brain CT, pupillary reflex, and GOS at 3 months were significantly correlated with high D-dimer value in traumatic patients (individual P < 0.001), but not in the non-traumatic group. Using receiver-operating characteristic curve (ROC), the cutoff point was 1496 microg/l, with sensitivity and specificity of 100% and 83%, respectively. D-dimer > or =1496 microg/l predicted a poor outcome [adjusted odds ratio (OR) 14.44, 95% CI 1.16-179.27; P = 0.038]. A high D-dimer level is associated with a poor outcome in patients with traumatic ICH. It can be used in addition to neurological assessment to predict the outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880559     DOI: 10.1111/j.1468-1331.2007.01908.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases.

Authors:  Heng-Li Tian; Hao Chen; Bing-Shan Wu; He-Li Cao; Tao Xu; Jin Hu; Gan Wang; Wen-Wei Gao; Zai-Kai Lin; Shi-Wen Chen
Journal:  Neurosurg Rev       Date:  2010-03-27       Impact factor: 3.042

2.  Impact of Coagulation Profile on Outcome of Head Injury.

Authors:  Gulzar Gupta; Chetan Wadhwa; Rajveer Garg; Ranbir S Dhaiya; Rakesh K Kaushal
Journal:  J Clin Diagn Res       Date:  2016-01-01

3.  The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.

Authors:  Michael V DeFazio; Richard A Rammo; Jaime R Robles; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  World Neurosurg       Date:  2013-01-08       Impact factor: 2.104

Review 4.  Surgical management of traumatic acute subdural hematoma in adults: a review.

Authors:  Hiroshi Karibe; Toshiaki Hayashi; Takayuki Hirano; Motonobu Kameyama; Atsuhiro Nakagawa; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-10-31       Impact factor: 1.742

Review 5.  Prognostic role of D-dimer level upon admission in patients with traumatic brain injury.

Authors:  Jing Zhang; Min He; Yanlin Song; Jianguo Xu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 6.  Neurocritical Management of Traumatic Acute Subdural Hematomas.

Authors:  Dong-Seong Shin; Sun-Chul Hwang
Journal:  Korean J Neurotrauma       Date:  2020-10-26

7.  Fibrinolytic Activation in Patients with Progressive Intracranial Hemorrhage after Traumatic Brain Injury.

Authors:  Kelly A Fair; David H Farrell; Belinda H McCully; Elizabeth A Rick; Elizabeth N Dewey; Cole Hilliard; Rondi Dean; Amber Lin; Holly Hinson; Ronald Barbosa; Martin A Schreiber; Susan E Rowell
Journal:  J Neurotrauma       Date:  2021-04-15       Impact factor: 5.269

8.  Usefulness of serum fibrin degradation products and D-dimer levels as biomarkers to predict return of spontaneous circulation in patients with cardiopulmonary arrest on arrival: comparison with acid-base balance.

Authors:  Shuichi Hagiwara; Masato Murata; Minoru Kaneko; Makoto Aoki; Masahiko Kanbe; Yoshio Ohyama; Jun'ichi Tamura; Kiyohiro Oshima
Journal:  Acute Med Surg       Date:  2014-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.